STOCK TITAN

[6-K] Aptorum Group Ltd Current Report (Foreign Issuer)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Aptorum Group Limited reported the results of its 2025 annual meeting of shareholders held on March 10, 2026. A total of 2,521,856 shares, representing 96.97% of the voting power entitled to vote, were present by proxy, establishing a strong quorum.

Shareholders voted on two proposals. For director elections, 180,344,392 votes were cast for Justin Wu, with 73,930 abstain/withheld, and 180,344,410 votes were cast for Douglas Arner, with 73,912 abstain/withheld. The second proposal received 180,394,457 votes for, 23,096 against and 769 abstentions, with no broker non-votes reported.

Positive

  • None.

Negative

  • None.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K 

  

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16 

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of March 2026

 

Commission File Number: 001-38764

  

APTORUM GROUP LIMITED

 

17 Hanover Square

London W1S 1BN, United Kingdom

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F      Form 40-F

 

 

 

 

 

 

On March 10, 2026, Aptorum Group Limited (the “Company”) held its 2025 annual meeting of shareholders (the “Annual Meeting”). At the Annual Meeting, the Company’s shareholders voted on two proposals. At the beginning of the Annual Meeting, a total of 2,521,856 shares, consisting of Class A Ordinary Shares and Class B Ordinary Shares, which represents 96.97% of the voting power of the shares entitled to vote at the Annual Meeting, were represented by proxy, which constituted a quorum for the transaction of business.

 

We are filing this Current Report on Form 6-K to disclose the voting results from the Annual Meeting. The following proposals were voted on:

 

  1. To re-elect the Class I directors to the Company’s board of directors (the “Board”).

  

Name  For  Abstain/Withheld
Mr. Justin Wu   180,344,392    73,930 
Mr. Douglas Arner   180,344,410    73,912 

 

  2. To approve, ratify and confirm the re-appointment of Marcum Asia CPAs LLP as the Company’s independent auditors for the year ending December 31, 2025, and to authorize the Board of Directors to fix their remuneration.

 

For   Against   Abstain
180,394,457   23,096   769

 

There were no broker non-votes with respect to either of Proposals 1 or 2.

 

The information in this Form 6-K shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

 

This Form 6-K is hereby incorporated by reference into the registration statements of the Company on Form S-8 (Registration Number 333-232591) and Form F-3 (Registration Number 333-292793) and into each prospectus outstanding under the foregoing registration statements, to the extent not superseded by documents or reports subsequently filed or furnished by the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  Aptorum Group Limited
     
Date: March 11, 2026 By: /s/ Ian Huen
    Name:  Ian Huen
    Title: Chief Executive Officer

 

 

FAQ

What did Aptorum Group (APM) disclose in its March 2026 Form 6-K?

Aptorum Group disclosed the voting results of its 2025 annual shareholder meeting. The filing details quorum levels, director election vote totals, and results for a second proposal, along with confirmation that there were no broker non-votes on either proposal.

How many Aptorum Group (APM) shares were represented at the 2025 annual meeting?

A total of 2,521,856 shares were represented by proxy at the meeting. This represented 96.97% of the voting power entitled to vote, meaning the company had a strong quorum to conduct official shareholder business and approve proposals.

What were the director election results for Aptorum Group (APM) in 2025?

Shareholders cast 180,344,392 votes for Justin Wu with 73,930 abstain or withheld. For Douglas Arner, 180,344,410 votes were for, with 73,912 abstain or withheld, confirming substantial support for both director nominees at the annual meeting.

How did shareholders vote on Aptorum Group’s (APM) second proposal?

The second proposal received 180,394,457 votes for, 23,096 votes against, and 769 abstentions. These results show strong approval among voting shareholders, with only a small portion voting against or abstaining on this item.

Were there any broker non-votes at Aptorum Group’s (APM) 2025 annual meeting?

There were no broker non-votes for either of the two proposals considered. This indicates that all shares held in street name and counted in the meeting’s voting power were either voted for, against, or abstained on each proposal.

How is this Aptorum Group (APM) 6-K used in relation to other SEC registrations?

The report is incorporated by reference into Aptorum Group’s existing registration statements on Form S-8 and Form F-3. This allows the disclosed meeting results to be treated as part of the information set in those effective registration statements.
Aptorum Group Ltd

NASDAQ:APM

View APM Stock Overview

APM Rankings

APM Latest News

APM Latest SEC Filings

APM Stock Data

6.40M
5.31M
Biotechnology
Healthcare
Link
United Kingdom
London